Classification of breast cancer cells on the basis of a functional assay for estrogen receptor

Molecular Medicine

Volumn 4, Issue 7, 1998, Pages 454-467

  Biswas, Debajit K ^a   Averboukh, Lidia ^a   Sheng, Shijie ^a   Martin, Kathy ^a   Ewaniuk, Darren S ^a   Jawde, Teddy F ^a   Wang, Feilan ^a   Pardee, Arthur B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DIMETHYL SULFOXIDE; ESTRADIOL; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; FULVESTRANT; HORMONE; MESSENGER RNA; RECEPTOR PROTEIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CLASSIFICATION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG SENSITIVITY; GENETIC TRANSFECTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; REPORTER GENE;

EID: 0031682218     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401751     Document Type: Article

References (55)

1. Topper J, Freedman C. (1980) Multiple hormone interactions in the development of the mammary gland. Physiol. Rev. 60: 1049-1060.
2. Jensen EV. (1996) Steroid hormones, receptors, and antagonists. Ann. N.Y. Acad. Sci. 784: 1-17.
3. Hedden A, Muller V, Jensen EV. (1995) A new interpretation of antiestrogen action. Ann. N.Y. Acad. Sci. 761: 109-120.
4. Shibata H, Spencer TE, Onate SA, Jenster GJ, Tsai SY, Tsai M-J, O'Malley BW. (1997) Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 52: 141-165.
5. Tsai M-J, O'Malley BW. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63: 451-486.
6. Kuiper GG, Gustafsson JA. (1997) The novel estrogen receptor-beta subtype: Potential role in the cell-and promoter-specific actions of estrogens and antiestrogens. FEBS Lett. 410: 87-90.
7. Brown M. (1994) Estrogen receptor molecular biology. Hematol. Oncol. North Am. 8: 101-111.
8. Henderson IC. (1991) Endocrine therapy of metastatic breast cancer. In: Harris JR, Hellman S, Henderson IC (eds). Breast Diseases. Lippincott, Philadelphia, pp. 559-603.
9. McDonnell DP, Dana SL, Hoener PA, Lieberman BA, Imhof MO, Stein RB. (1995) Cellular mechanisms which distinguish between hormone-and anti-hormone-activated estrogen receptor. Ann. N.Y. Acad. Sci. 761: 121-137.
10. Evans RM. (1988) The steroid and thyroid hormone receptor superfamily. (1988) Science 240: 889-895.
11. Jensen EV. (1981) Hormone dependency in breast cancer. Breast Cancer Res. Treat. 26: 2319-2326.
12. Scott JA, McGuire WL. (1991) New molecular markers of prognosis in breast cancer. In: Endocrine-Dependent Tumors. Voigt K-D, Knabbe C (eds). Raven Press, New York, pp. 179-196.
13. Witliff JL. (1984) Steroid hormone receptors in breast cancer. Cancer 53: 630-640.
14. Peterson OW, Hoyer PE, Van Deurs B. (1984) Frequency and distribution of estrogen receptor positive cells in normal, nonlactating human breast. Cancer Res. 47: 5748-5751.
15. Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson NSB, Gazet J-C, Nolan C, Coombes RC. (1991) Estrogen and progesterone receptors in the normal female breast. Cancer Res. 51: 1817-1822.
16. Dauvois S, Danielian PS, White R, Parker MG. (1992) Anti-estrogen ICI 164,384 reduces cellular estrogen receptor content by increasing ils turnover. Proc. Natl. Acad. Sci. U.S.A. 89: 4037-4041.
17. Rio MC, Bellocq JP, Gairard B, Rasmussen UB, Krust A, Koehl C, Calderoli H, Schilf V, Renaud R, Chambon P. (1987) Specific expression of the PS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc. Natl. Acad. Sci. U.S.A. 84: 9243-9247.
18. Fuqua SAW, Chamness GC, McGuire WL. (1993) Estrogen receptor mutations in breast cancer. J. Cell. Biochem. 51: 135-139.
19. Zhang Q-X, Borg A, Wolf DM, Oesterreich S, Fuqua SAW. (1997) An estrogen receptor mutant with strong hormone-independent activity from metastatic breast cancer. Cancer Res. 57: 1244-1249.
20. Reese JC, Katzenellenbogen BS. (1992) Examination of the DNA-binding ability of estrogen receptor in whole cells: Implications for hormone-independent transactivation and the actions of anti-estrogens. Mol. Cell. Biol. 12: 4531-4538.
21. Leygue ER, Watson PH, Murphy LC. (1996) Estrogen receptor varients in normal human mammary tissue. J. Natl. Cancer Inst. 88: 284-290.
22. Gotteland M, Desauty G, Delarue JC, Liu L, May E. (1995) Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues. Mol. Cell. Endocrinol. 112: 1-13.
23. Nicholson RI, Gee JMW, Manning DL, Wakeling AE, Montano MM, Katzenellenbogen BS. (1995) Response to pure anti-estrogens (ICI 164,384, ICI 182,780) in estrogen sensitive and resistant experimental and clinical breast cancer. Ann. N.Y. Acad. Sci. 761: 148-163.
24. Kumar V, Chambon P. (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55: 145-156.
25. Zwijsen RML, Wientjens E, Klompmaker R, Sman JV-D, Bernards R, Michalides JAM. (1997) CDK-independent activation of estrogen receptor by cyclin D1. Cell 88: 405-415.
26. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Philip HW, Dowdy SF, Brown M, Ewen ME. (1997) Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17: 5338-5347.
27. Smith CL, Connely M, O'Malley BW. (1993) Modulation of the ligand-independent activation of the human estrogen receptor by hormone and anti-hormone. Proc. Natl. Acad. Sci. U.S.A. 90: 6120-6124.
28. Hanstein B, Eckner R, DiRenzo J, Halamachi S, Liu H, Searchy B, Kurokawa R, Brown M. (1996) p300 is a component of an estrogen receptor complex. Proc. Natl. Acad. Sci. U.S.A. 93: 11540-11545.
29. Halachmi S, Marden E, Martin G, Mackay H, Abbondanza C, Brown M. (1994) Estrogen receptor-associated proteins: Possible mediators of hormone induced transcription. Science 264: 1455-1458.
30. Kraus WL, Weis KE, Katzenellenbogen BS. (1995) Inhibitory cross-talk between steroid receptors: Differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist-and antagonist-occupied progestin receptors. Mol. Cell. Biol. 15: 1847-1857.
31. Yang NN, Venugopalan M, Hardikar S, Glasebrook A. (1996) Identification of an estrogen response element activated by metabolites of 17 β-estradiol and raloxifene. Science 273: 1222-1225.
32. Sukovich DA, Mukherjee R, Benfield, PA. (1994) A novel cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element. Mol. Cell. Biol. 14: 7134-7143.
33. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A. (1996) Cloning of a novel estrogen receptor expressed in prostate and overy. Proc. Natl. Acad. Sci. U.S.A. 93: 5925-5930.
34. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lupu, R. (1998) Expression of estrogen receptor β messenger RNA variant in breast cancer. Cancer Res. 58: 210-214.
35. Schodin DJ, Zhuang Y, Shapiro DJ, Katzenellenbogen BS. (1995) Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness. J. Biol. Chem. 270: 31163-31171.
36. Berry M, Nunez A-M, Chambon P. (1989) Estrogen responsive element of the PS2 gene is an imperfect palindromic sequence. Proc. Natl. Acad. Sci. U.S.A. 86: 1218-1223.
37. Klein-Hitpass L, Tsai SY, Greene GL, Clark JH, Tsai M-J, O'Malley BW. (1989) Specific binding of estrogen receptor to the estrogen response element. Mol. Cell. Biol. 9: 43-49.
38. Sager R, Sheng S, Anisowicz A, Sotiropoulou G, Zou Z, Stenman G, Swisshelm K, Chen Z, Hendrix MJC, Pemberton P, Rafidi K, Ryan K. (1994) RNA genetics of breast cancer: Maspin as a paradigm. Cold Spring Harb. Symp. Quant. Biol. 59: 537-547.
39. Zajchowski DA, Band V, Trask DK, Kling D, Connolly JL, Sager, R. (1990) Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 87: 2314-2318.
40. Dignam JD, Lebovitz RM, Roeder RD. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids Res. 11: 1475-1489.
41. Biswas DK, Ahlers CM, Dezube BJ, Pardee AB. (1993) Cooperative inhibition of NF-kB-Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat. Proc. Nat. Acad. Sci. U.S.A. 90: 11044-11048.
42. Biswas DK, Salas TR, Wang F, Ahlers CM, Dezube BJ, Pardee AB. (1995) A Tat-induced auto-upregulatory loop for superactivation of the human immunodeficiency virus type-1 promoter. J. Virol. 69: 7437-7444.
43. Harlow E, Lane D. (1988) In: Antibodies, A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 392-397.
44. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. (1994) DNA-protein interactions: Rapid separation of protein-bound DNA from free DNA using nitrocellulose filters. In: Chodash LA (ed). Current Protocols in Molecular Biology. Current Protocols, John Wiley & Sons, Inc., New York, pp. 12.8.1-12.8.5.
45. Liang P, Pardee AB. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971.
46. Martin K, Kwan C-P, Sager R. (1997) A direct-sequencing-based strategy for identifying and cloning cDNAs from differential display gels. In: Pardee AB, Liang P (eds). Methods in Molecular Biology. Differential Display: Methods and Applications. Humana Press, Totowa, NJ, pp. 77-85.
47. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. (1990) Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
48. Martin K, Kwan C-P, O'Hare MJ, Pardee AB, Sager S. (1998) Identification and verification of differential display cDNAs using gene-specific primers and hybridization arrays. Cancer Res. Techniques 24: 1018-1026.
49. Ozawa M. (1995) Structure of the gene encoding mouse reticulocalbin, a novel endoplasmic reticulum-resident Ca (2+)-binding protein with multiple EF-hand motifs. J. Biochem. (Tokyo) 118: 154-160.
50. Scherer PE, Lederkremer GZ, Williams S, Fogliano M, Baldini G, Lodish HF. (1996) Cab45, a novel (Ca2+)-binding protein localized to the Golgi lumen. J. Cell. Biol. 133: 257-268.
51. Liu Z, Brattain MG, Appert H. (1997) Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435s, versus the poorly invasive cell line, MCF-7. Biochem. Biophys. Res. Commun. 231: 283-289.
52. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, Mcdonnell DP, Nawaz Z, O'Malley BW, McGuire WL. (1991) Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 51: 105-109.
53. Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai M-J, O'Malley BW. (1992) Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267: 19513-19520.
54. Furlow DJ, Murdoch FE, Gorski J. (1993) High affinity binding of estrogen receptor to a DNA response element does not require homodimer formation or estrogen. J. Biol. Chem. 268: 12519-12525.
55. Mosman T. (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assay. J. Immunol. Methods 65: 55-64.